 Brokerages expect Corvus Pharmaceuticals Inc NASDAQ:CRVS to report 0.30 earnings per share EPS for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Corvus Pharmaceuticals earnings, with estimates ranging from 0.43 to 0.24. Corvus Pharmaceuticals reported earnings per share of 0.44 during the same quarter last year, which would ... 